The Effect of Ambroxol on the Serum Cytokines of Patients with Acute Respicatory Distressed Syndrome (ARDS)

ZHANG Qing,YUAN Shi-ying,YAO Shang-long
DOI: https://doi.org/10.3969/j.issn.1009-5918.2008.01.008
2008-01-01
Abstract:Objective To investigate the effect of Ambroxol on the serum IL-1β,IL-6,IL-8,TNF-α,GM-CSF and IL-10 and blood gas of patients with ARDS.Methods 40 patients with ARDS were enrolled in the study.They were ran- domly divided into 2 group.Patients in group A were treated only with 0.9% NaCl (500 ml),in group B with Ambroxol(20 mg/kg) +0.9% NaCl (500ml) for 7 consecutive days.The blood samples for blood gas and the serum IL-1β,IL-6,IL-8, TNF-α,GM-CSF and IL-10 measurements were taken before the first infusion,5 day and 7 days following the first infusion respectively,Outcome of patients in both groups were analyzed.Results The blood gas indices of the patient in group B im- proved significantly(P<0.05),which were much better than those of group A (P<0.05).The serum IL-1β,IL-6,IL-8, TNF-α and GM-CSF of the patients in group B significantly declined (P<0.05),whereas IL-10 significantly increased comparing to the corresponding serum concentrations in group A after 7 days treatment respectively (P<0.05).Conclu- sion Ambroxol could inhibit the secretion of pro-inflammatory cytokines,but facilitate the secretion of anti-inflammatory cytokines of patient with ARDS.Pulmonary function of ARDS patients could benefit from clinical application of Ambroxol.
What problem does this paper attempt to address?